---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-013173"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T11:54:01.567138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Pliant Therapeutics launches underwritten public offering; terminates ATM prospectus

## Summary
- Company commenced an underwritten public offering of common stock; terms not disclosed.
- No shares were sold under prior $150M ATM facility from July 2021 to January 2023.
- Existing Sales Agreement with Cantor Fitzgerald remains in effect but no sales until new prospectus filed.
- Offering made via effective shelf registration statement (Form S-3).

## SEC filing metadata
- accession: 0001193125-23-013173
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/0001193125-23-013173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/d428465d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-013173
- JSON: https://secwatch.observer/filing/0001193125-23-013173.json
- Plain text: https://secwatch.observer/filing/0001193125-23-013173.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.